Literature DB >> 24463071

Rational design of a series of novel amphipathic cell-penetrating peptides.

Jakob Regberg1, Artita Srimanee2, Mikael Erlandsson3, Rannar Sillard3, Dimitar A Dobchev4, Mati Karelson5, Ulo Langel6.   

Abstract

A series of novel, amphipathic cell-penetrating peptides was developed based on a combination of the model amphipathic peptide sequence and modifications based on the strategies developed for PepFect and NickFect peptides. The aim was to study the role of amphipathicity for peptide uptake and to investigate if the modifications developed for PepFect peptides could be used to improve the uptake of another class of cell-penetrating peptides. The peptides were synthesized by solid phase peptide synthesis and characterized by circular dichroism spectroscopy. Non-covalent peptide-plasmid complexes were formed by co-incubation of the peptides and plasmids in water solution. The complexes were characterized by dynamic light scattering and cellular uptake of the complexes was studied in a luciferase-based plasmid transfection assay. A quantitative structure-activity relationship (QSAR) model of cellular uptake was developed using descriptors including hydrogen bonding, peptide charge and positions of nitrogen atoms. The peptides were found to be non-toxic and could efficiently transfect cells with plasmid DNA. Cellular uptake data was correlated to QSAR predictions and the predicted biological effects obtained from the model correlated well with experimental data. The QSAR model could improve the understanding of structural requirements for cell penetration, or could potentially be used to predict more efficient cell-penetrating peptides.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cell-penetrating peptide; Model amphipathic peptide; Plasmid transfection; QSAR; Structure–activity

Mesh:

Substances:

Year:  2014        PMID: 24463071     DOI: 10.1016/j.ijpharm.2014.01.018

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  8 in total

Review 1.  A role for peptides in overcoming endosomal entrapment in siRNA delivery - A focus on melittin.

Authors:  Kirk K Hou; Hua Pan; Paul H Schlesinger; Samuel A Wickline
Journal:  Biotechnol Adv       Date:  2015-05-27       Impact factor: 14.227

Review 2.  Delivery of nucleic acids and nanomaterials by cell-penetrating peptides: opportunities and challenges.

Authors:  Yue-Wern Huang; Han-Jung Lee; Larry M Tolliver; Robert S Aronstam
Journal:  Biomed Res Int       Date:  2015-03-26       Impact factor: 3.411

3.  Magnetic Nanoparticle Assisted Self-assembly of Cell Penetrating Peptides-Oligonucleotides Complexes for Gene Delivery.

Authors:  Moataz Dowaidar; Hani Nasser Abdelhamid; Mattias Hällbrink; Krista Freimann; Kaido Kurrikoff; Xiaodong Zou; Ülo Langel
Journal:  Sci Rep       Date:  2017-08-22       Impact factor: 4.379

4.  A retro-inverso cell-penetrating peptide for siRNA delivery.

Authors:  Anaïs Vaissière; Gudrun Aldrian; Karidia Konate; Mattias F Lindberg; Carole Jourdan; Anthony Telmar; Quentin Seisel; Frédéric Fernandez; Véronique Viguier; Coralie Genevois; Franck Couillaud; Prisca Boisguerin; Sébastien Deshayes
Journal:  J Nanobiotechnology       Date:  2017-04-28       Impact factor: 10.435

Review 5.  Combination of Cell-Penetrating Peptides with Nanoparticles for Therapeutic Application: A Review.

Authors:  Sara Silva; António J Almeida; Nuno Vale
Journal:  Biomolecules       Date:  2019-01-10

Review 6.  A Second Life for MAP, a Model Amphipathic Peptide.

Authors:  Sara Silva; Kaido Kurrikoff; Ülo Langel; António J Almeida; Nuno Vale
Journal:  Int J Mol Sci       Date:  2022-07-28       Impact factor: 6.208

7.  Identification of a Short Cell-Penetrating Peptide from Bovine Lactoferricin for Intracellular Delivery of DNA in Human A549 Cells.

Authors:  Betty R Liu; Yue-Wern Huang; Robert S Aronstam; Han-Jung Lee
Journal:  PLoS One       Date:  2016-03-04       Impact factor: 3.240

Review 8.  Cell-Penetrating Peptides and Transportan.

Authors:  Ülo Langel
Journal:  Pharmaceutics       Date:  2021-06-29       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.